Gene therapy for ADA-SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products.
about
Long term outcomes of severe combined immunodeficiency: therapy implications.Preclinical and clinical advances in transposon-based gene therapy.Progress in biopharmaceutical development.Triple-Gene Therapy for Stroke: A Proof-of-Concept in Vivo Study in Rats.Gene therapy in rare diseases: the benefits and challenges of developing a patient-centric registry for Strimvelis in ADA-SCID.Adenosine deaminase deficiency: a review.Lessons learned from lung and liver in-vivo gene therapy: implications for the futureApproaches for Effective Clinical Application of Stem Cell TransplantationRecent Progress in European Advanced Therapy Medicinal Products and BeyondGenetic Strategies for HIV Treatment and PreventionPreclinical Development of Cell-Based Products: a European Regulatory Science PerspectiveImpact of biobanks on research outcomes in rare diseases: a systematic review
P2860
Q45872036-61EEE86B-E30D-4CE1-B5B5-FE8AE054493DQ45873802-BCAC5900-BA88-4706-BF67-CF2CD3EFABFEQ48253463-F08129E7-D26E-4D1A-AEC1-320AF8383BE3Q50350373-11237975-CB93-41FC-A313-FADA366A0E62Q52602018-F65744DF-99CC-4FAC-9758-B7D330FA1DFAQ54229015-3F42F1E6-0DA6-4F8B-9875-4C17BEE12EBCQ57163666-8063D7D3-F963-4A04-BAF6-0B3C043FE475Q57179325-E6C2C79C-7505-448F-9945-45B4D37CEA30Q57299991-EEFC8D06-4185-47ED-BB18-B547E9A770B3Q58604627-C8ACB648-1A66-4963-B5B8-886979D010BCQ58737780-D1E2D53F-5ABA-41FD-B841-17E1E0E1E899Q59127575-512AFC19-2B00-4302-BE19-247ED3CE364E
P2860
Gene therapy for ADA-SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Gene therapy for ADA-SCID, the ...... ed therapy medicinal products.
@ast
Gene therapy for ADA-SCID, the ...... ed therapy medicinal products.
@en
type
label
Gene therapy for ADA-SCID, the ...... ed therapy medicinal products.
@ast
Gene therapy for ADA-SCID, the ...... ed therapy medicinal products.
@en
prefLabel
Gene therapy for ADA-SCID, the ...... ed therapy medicinal products.
@ast
Gene therapy for ADA-SCID, the ...... ed therapy medicinal products.
@en
P2860
P356
P1476
Gene therapy for ADA-SCID, the ...... ed therapy medicinal products.
@en
P2093
Maria Grazia Roncarolo
P2860
P304
P356
10.15252/EMMM.201707573
P577
2017-04-10T00:00:00Z